Population Pharmacokinetics of Esketamine Nasal Spray and its Metabolite Noresketamine in Healthy Subjects and Patients with Treatment-Resistant Depression Read More > October 31, 2020
Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression Read More > October 29, 2020
Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial Read More > October 29, 2020
Predicting therapeutic response to oral ketamine for chronic suicidal ideation: a Bayesian network for clinical decision support Read More > October 28, 2020
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence Read More > October 11, 2020
Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis Read More > September 23, 2020
Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder Read More > September 8, 2020
Total Recall: Lateral Habenula and Psychedelics in the Study of Depression and Comorbid Brain Disorders Read More > September 7, 2020
Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials Read More > September 5, 2020
The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication Read More > August 28, 2020
